Centus Biotherapeutics
Industry
- Biotechnology
See more in Biomedtracker
Latest on Centus Biotherapeutics
Generics Bulletin
• By Dean Rudge
Centus Biotherapeutics , the UK-based joint venture between AstraZeneca and Fujifilm Kyowa Kirin Biologics, has been sued for patent infringement in a Texas district court in light of Centus’ FKB238
Generics Bulletin
• By Dave Wallace
Centus Biotherapeutics , the joint venture between Fujifilm Kyowa Kirin Biologics and AstraZeneca, has received formal European Commission approval for its Equidacent (bevacizumab) biosimilar version
Pink Sheet
• By Neena Brizmohun
The European Medicines Agency has this week recommended for EU approval a raft of new drugs, including Blenrep (belantamab mafodotin), GlaxoSmithKline ’s first-of-a-kind treatment for multiple myelom